Cargando…
Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
Combination therapy for type 2 diabetes using agents with complementary mechanisms of action may improve glycemic control to a greater extent than monotherapy and allow the use of lower doses of antihyperglycemic medications. Dipeptidyl peptidase-4 inhibitors, including saxagliptin, are recommended...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220591/ https://www.ncbi.nlm.nih.gov/pubmed/25646943 http://dx.doi.org/10.2337/diaclin.32.4.170 |